Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Erdenetuya Myagmarsuren"'
Publikováno v:
Central Asian Journal of Medical Sciences, Vol 9, Iss 4, Pp 189-194 (2023)
Objectives: The impact of COVID-19 prompted a race to find a treatment that would reduce its mortality. This study aimed to analyze how the clinical and laboratory characteristics reflect the disease process and progression of COVID-19 cases in hospi
Externí odkaz:
https://doaj.org/article/a66c2289fd89478b98785b4fa8d0f3a3
Legislation and current developments in adverse drug reaction reporting in Mongolia: how far are we?
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 14, Iss 1 (2021)
Monitoring adverse drug reactions is a vital issue to ensure drug safety and to protect the general public from medication-related harmful effects. In order to properly monitor drug safety, a regulatory system needs to be in place as well as an infra
Externí odkaz:
https://doaj.org/article/f8eef52c62f241bfb85dbf549a2cafda
Publikováno v:
Asian Pacific Journal of Health Sciences. 8:38-44
As cardiovascular diseases are the major global health problem, the management of cardiovascular medicines (CVMs) should not be out of attention. We aimed to identify CVMs needing strict management control, used in 2017 and 2018 to investigate if the
Autor:
Ankhtuya Batsukh, Dashdulam Ganbold, Otgonjargal Olonbayar, Ariunaa Damdinsuren, Buuvee Bayarkhangai, Davaadulam Baljinnyam, Enkhbaatar Ulziikhishig, Perleidulam Bunddulam, Undrakh Batbayar, Munkhbat Sukhee, Erdenetuya Myagmarsuren
Publikováno v:
Central Asian Journal of Medical Sciences. 5:236-242
Legislation and current developments in adverse drug reaction reporting in Mongolia: how far are we?
Publikováno v:
Journal of Pharmaceutical Policy and Practice, 14(1):15. SPRINGERNATURE
Journal of Pharmaceutical Policy and Practice, Vol 14, Iss 1, Pp 1-8 (2021)
Journal of Pharmaceutical Policy and Practice
Journal of Pharmaceutical Policy and Practice, Vol 14, Iss 1, Pp 1-8 (2021)
Journal of Pharmaceutical Policy and Practice
Monitoring adverse drug reactions is a vital issue to ensure drug safety and to protect the general public from medication-related harmful effects. In order to properly monitor drug safety, a regulatory system needs to be in place as well as an infra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9631d76c21ef981da967eb47b2615dd1
https://research.rug.nl/en/publications/879947a7-8080-4e94-93aa-6ab9e801ae84
https://research.rug.nl/en/publications/879947a7-8080-4e94-93aa-6ab9e801ae84